Location: Atlanta, GA
CIK: 0001882053 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $428M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TFX | TELEFLEX INCORPORATED | 387,388 | $49.11M | 11.5% | — | — | COM | 879369106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 415,641 | $48.66M | 11.4% | — | — | COM | 604749101 |
| CI | THE CIGNA GROUP | 159,290 | $43.91M | 10.3% | — | — | COM | 125523100 |
| IONS | IONIS PHARMACEUTICALS INC | 519,977 | $41.23M | 9.6% | — | — | COM | 462222100 |
| UNH | UNITEDHEALTH GROUP INC | 88,687 | $36.86M | 8.6% | — | — | COM | 91324P102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 583,219 | $33.37M | 7.8% | — | — | COM | 09061G101 |
| GRDN | GUARDIAN PHARMACY SVCS INC | 711,939 | $29.81M | 7.0% | — | — | CL A | 40145W101 |
| VSTS | VESTIS CORPORATION | 1,900,140 | $27.59M | 6.5% | — | — | COM SHS | 29430C102 |
| BBIO | BRIDGEBIO PHARMA INC | 339,720 | $25.3M | 5.9% | — | — | COM | 10806X102 |
| PNTG | PENNANT GROUP INC | 515,818 | $19.06M | 4.5% | — | — | COM | 70805E109 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 615,287 | $14.89M | 3.5% | — | — | COM | 61225M102 |
| KOD | KODIAK SCIENCES INC | 378,010 | $14.73M | 3.4% | — | — | COM | 50015M109 |
| TNGX | TANGO THERAPEUTICS INC | 455,605 | $14.24M | 3.3% | — | — | COM | 87583X109 |
| KYMR | KYMERA THERAPEUTICS INC | 113,173 | $12.98M | 3.0% | — | — | COM | 501575104 |
| CGEM | CULLINAN THERAPEUTICS INC | 704,442 | $12.83M | 3.0% | — | — | COM | 230031106 |
| ANL | ADLAI NORTYE LTD | 258,390 | $2.971M | 0.7% | — | — | SPONSORED ADS | 00704R109 |